Soft tissue filling with hyaluronic acid;Les comblements par l'acide hyaluronique

Annales de Chirurgie Plastique Esthetique

Volumn 49, Issue 5, 2004, Pages 465-485

  Ascher, B ^a   Cerceau, M ^b   Baspeyras, M ^b   Rossi, B ^b  

^a Clinique Iena   (France)

^b NONE   (France)

Author keywords

Acide hyaluronique; Effets secondaires; Hyaluronic acid; Implants r sorbables; Legal aspects; L gislation; Overview; Panorama; Pharmacologie; Pharmacology; Resorbables soft tissue fillers; Rides; Side effects; Technique; Wrinkles

Indexed keywords

COLLAGEN; HYALURONIC ACID;

ALLERGIC REACTION; ANESTHESIA; BIOCOMPATIBILITY; CHICKEN; CLINICAL TRIAL; COMB; DRUG EFFICACY; DRUG HALF LIFE; DRUG MANUFACTURE; DRUG SAFETY; ESTHETIC SURGERY; EXTRACTION; FERMENTATION; HUMAN; PLASTIC SURGERY; REVIEW; SIDE EFFECT; SOFT TISSUE;

EID: 7444232089     PISSN: 02941260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anplas.2004.09.001     Document Type: Article

References (64)

1. K. Meyer, and J.W. Palmer The polysaccharide of the vitreous humor J. Biol. Chem. 107 1934 629 634
2. G. Abatangelo, and P. Weigel New Frontiers in Medical Sciences: Redefining Hyaluronan 2000 Elsevier Amsterdam
3. K.L. Goa, and P. Benfield Hyaluronic acid. Review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing Drugs 47 1994 536 566
4. M.E. Adams An analysis of clinical studies of the use of crosslinked hyaluronan, Hylan, in treatment of osteoarthritis J. Rheumatol. 20 Suppl. 39 1993 16 18
5. D.B. Johns, T.C. Kiorpes, K.E. Rodgers, and G.S. Dizeruga Fertil. Steril. 68 1997 137
6. G. Lockgren, N. Wahlin, E. Skololenberg, and A. Stenberg Long term follow up of children treated with dextranomer/hyaluronic acid copolymer for vesicouretral reflux J. Urol. 166 5 2001 1887 1892
7. R.W. Chan, and I.R. Titze Viscosities of implantable biomaterials in vocal cord augmentation surgery Laryngoscope 108 1998 725
8. Y.J. Chen Abatangelo G. Functions of hyaluronan in wound repair J. Wound Care 89 1999 435 442
9. N.E. Larsen, C.T. Pollac, K. Reiner, E. Leshchiner, and E.A. Balazs Hilan Gel biomaterial:dermal and immunologic compatibility J. Biomed. Mater. Res. 9 1993 1129 1134
10. M. Olenius The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and fold Aesth. Plast. Surg. 22 1998 97 101
11. F. Duranti, G. Salti, B. Bovani, M. Calanda, and M.L. Rosati Injectable hyaluronic acid for soft tissue augmentation Derm. Surg. 24 1998 1317 1325
12. st Ann. Meeting, Dec. 5-10, 1992, San Francisco CA.
13. N. Yui Inflammation responsive degradation of crosslinked hyaluronic acid gels J. Controlled Release 22 1992 105 116
14. R. Barbucci New Frontiers in Medical Sciences: Redifining hyaluronan 2000 Elsevier Amsterdam 203 212
15. G.D. Prestwich, D.M. Marecak, J.F. Marecek, K.P. Vercruysse, and M.R. Ziebell Controlled chemical modification of hyaluronic acid: synthesis, applications and biodegradation of hydrazide derivatives J. Controlled Release 53 1997 99
16. T.C. Laurent, K. Hellsing, and B. Gelotte Cross-linked gels of hyaluronic acid Acta Chem. Scand. A 18 1964 274 275
17. J.W. Kuo, D.A. Swann, and G.D. Prestwich Chemical modification of hyaluronic acid by carbodiimides Bioconjugate Chem. 2 1991 232 241
18. T.C. Laurent The Chemistry. Biology and Medical Applications of Hyaluronan and its Derivatives Wenner-Gren International Series Vol. 72 1998 Portland Press London
19. K. Kazuaki Hyaluronic acid:separation and biological implications J. Chromatogr. B797 2003 347 355
20. E.A. Balazas, and J.L. Denlinger Clinical uses of hyaluronan. The biology of hyaluronan. Wieley. Chichester Ciba Found. Symp. 143 1989 65 280
21. Code de la santé publique(Partie Législative) Article L5111-1.
22. Code de la santé publique(Nouvelle partie Législative) Article L5111-1.
23. ER:Dispositifs médicaux. Articles L.5211-1 et suivants.
24. G. Lemperle, V. Morhenn, and U. Charrier Human histology and persistence of various injectable filler substances for soft tissue augmentation Aesth.Plast.Surg. 27 2003 354 366
25. Code de la santé publique(Partie réglementaire- Décrets en Conseil d'Etat) Article R665-48.
26. Code de la santé publique(Nouvelle partie Législative) Article L5461-2.
27. Code de la santé publique(Partie Réglementaire- Décrets en Conseil d'Etat) ArticleL665-50.
28. F. Manna, M. Dentini, and P. Desideri Comparative chemical evaluation of tow commercially available derivative of hyaluronic acid (hylaform® from rooster combs and Restylane® from steptococcus) used for soft tissue augmentation J.Eur. Acad. Derm Vener. 13 1999 183 192
29. A. Pons-Guiraud Matériaux de comblement:techniques et effets indésirables EMC Dermatologie Cosmétologie 1 2004 59 74
30. K. Coleman Moriaty Hyaluronic acid and others fillers. In botulinum toxin in facial rejuvenation 2004 Mosby 105 117
31. J. Reinmüller Hyaluronic Acid Aesth. Surg. J. 23 2003 309 311
32. L. Belhaouari, J.Y. Bailly, V. Gassia, and M. Costagliola Rajeunissement des lévres:gestion des indications J. Med. Esth. et Chir. Dermatol. Vol. XXX 2003 29 34
33. M. Bousquet, and B. Agerup Restylane lip augmentation:european experience. Opérative techniques in occuloplastic orbital and reconstructive surgery 2 4 1999 172 176
34. M. Zbili Classification des lévres et protocoles thérapeutiques J. Med. Esth. et Chir. Dermatol. Vol. XXXI 2004 17 24
35. R.L. Cucin, and D. Barek Complications of injectable collagen implant Plast. Reconst. Surg. 71 1983 731
36. Ascher B, Wibault-Collange C. Botulunum toxin (Dysport®) and hyaluronique acid (Hylaform®) association in the lines treatments. A preliminary evaluation. In Inamed aesthetics news. November 2002, no 1.
37. M. Pistor 1964 MALOINE Paris
38. J. Le Coz Revitalisation du visage. In:traité de mésothérapie 2004 Masson 234 235
39. C. De Goursac le mesolift:une approche progressive de la rétraction cutanée J. Med. Esth. et Chir. Dermatol. Vol. XXX no 117 2003
40. M. Tordjman Rajeunissement cutané du décolleté par mésothérapis J.Med. Esth. Chir. Dermat. 118 2003 111 118
41. K. Coleman Moriaty Other solutions. Combinations treatments. In:botulinum toxin in facial rejuvenation K. Coleman Moriaty 2004 Mosby 128 129
42. B. Sommer, and G. Sattler Cosmetic indications according to anatomic region Botulinum toxin in aesthetic medecine 2001 Blackwell science Berlin, Vienna
43. Carruthers J.D.A., Carruthers A., and Maberley D. Deep resting glabellar rhytides respond to BTX-A and Hylan B Dermatol Surg 29 5 May 2003 539 544
44. J.D.A. Carruthers, and A. Carruthers A prospective, randomized, parallel group study analysing the effect of BTX-A (Botox) and noanimal sourced hyaluronic acid (NASHA, Restylane®) in combination compared with NASHA (Restylane®) alone in severe glabellar rytides in adult female subject Dermatol. Surg. 29 8 2003 802 809
45. A. Pons-Guiraud Actualisation des effets secondaires des produits de comblement Nouv. Dermatol. 22 2003 205 210
46. C. Hoffman Schuller-Petrovic S,soyer HP,Kerl H, Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials J. Am. Acad. Dermatol. 40 1999 100 1023
47. R. Barr, and S.J. Stegman Delayed skin test reaction to injectable collagene implant (Zyderm).The histopathologic comparative study J. Am. Acad. Dermatol. 10 1984 652 658
48. G. Charriere, M. Bejot, L. Schnitzler, G. Vikle, and D.J. Hartmann Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients J. Am. Acad. Dermatol. 21 1989 1203 1208
49. D.P. Clark, C.W. Hanke, and N.A. Swanson Dermal implants;safety of products injected for soft tissue augmentation J. Am. Acad. Dermatol. 21 1989 992 998
50. J.R. Lupton, and T.S. Alster Cutaneous hypersensitivity reaction to injectable acid gel Dermatol. Surg. 26 2000 135 137
51. J.R. Lupton, and T.S. Alster Cutaneous hyopersensitivity reaction to injectable hyaluronic acide gel Aesthetic Plast. Surg. 22 2 1998 97 101
52. R.S. Narins, F. Brandt, J. Leyden, Z.P. Lorenc, M. Rubin, and S.A. Smith Randomized double-blind multicenter comparaison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds Dermatol. Surg. 29 6 2003 588 595
53. F. De Lustro, J. Fries, and J. Kang Immunity to injectable collagen and auto-immune disease ; a summary of current understanding J. Dermatol. Surg. Oncol. 14 Suppl. 1 1988 57 65
54. C. Bergeret-Galley Comparaison of resorbable soft tissue fillers J. Aest.Surg. 24 1 2004 33 45
55. P. Bui, A. Pons-Guiraud, and R. Kuffer Injectables lentement et non résorbables Ann. Chir. Plast. Esth. 2004 (In Press)
56. A.W. Klein, and M.L. Elson The history of substances for soft tissue augmentation Dermatol. Surg. 26 2000 1096
57. B.M. Kinney, and C.E. Hughes III Soft tissue fillers:an overview J. Aesth Surg. 21 2001 469
58. D. Piacquadio, M. Jarcho, and R. Goltz Hylan gel (Hylaform) as a soft tissue augmentation material A.W. Klein Tissue augmentation in clinical practice:procedures and techniques 1998 Marcel Decker New York 269 291
59. G. Bes Efficacité du Juvederm 30:un an de suivit Réalités Thérap Dermat. Vener. 127 2003 45 49
60. A.W. Klein Injectable Bovine Collagen A.W. Klein Tissue augmentation in clinical practice:procedures and techniques 1998 Marcel Decker New York 125 144
61. N.J. Lowe, C.A. Maxwell, P. Lowe, M.G. Duick, and K. Shah Hyaluronic acid skin fillers:adverse réactions and skin testing J. Am. Acad. Dermatol. 45 2001 930 933
62. P. Micheels Human anti-hyaluronic acid antibodies. Is it possible? Dermatol. Sur. 27 2001 185 191
63. P.M. Friedman, E.A. Mafong, A.N. Kauvar, and R.G. Geronimus Safety data of injectable noanimal stabilized hyaluronic acid gel for soft tissue augmentation J. Dermatol. Surg. 28 2002 491 494
64. J. Reinmuller Safety and efficacy of a double crosslinked hyaluronic acid-based dermal filler (Hyalite) Am. Soc. Aesth. Plast. Surg. (Vancouver) 2004 (Communication)